KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Accounts Payables (2016 - 2025)

Historic Accounts Payables for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to $383.7 million.

  • BeOne Medicines' Accounts Payables rose 2475.97% to $383.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $383.7 million, marking a year-over-year increase of 2475.97%. This contributed to the annual value of $405.0 million for FY2024, which is 2852.52% up from last year.
  • As of Q3 2025, BeOne Medicines' Accounts Payables stood at $383.7 million, which was up 2475.97% from $360.8 million recorded in Q2 2025.
  • BeOne Medicines' 5-year Accounts Payables high stood at $405.0 million for Q4 2024, and its period low was $146.9 million during Q1 2021.
  • For the 5-year period, BeOne Medicines' Accounts Payables averaged around $288.4 million, with its median value being $294.8 million (2022).
  • Its Accounts Payables has fluctuated over the past 5 years, first surged by 6125.11% in 2022, then crashed by 1004.07% in 2024.
  • Quarter analysis of 5 years shows BeOne Medicines' Accounts Payables stood at $262.4 million in 2021, then grew by 12.34% to $294.8 million in 2022, then grew by 6.9% to $315.1 million in 2023, then rose by 28.53% to $405.0 million in 2024, then dropped by 5.26% to $383.7 million in 2025.
  • Its Accounts Payables stands at $383.7 million for Q3 2025, versus $360.8 million for Q2 2025 and $364.5 million for Q1 2025.